Back

Changes in antithrombotic therapy after atrial fibrillation diagnosis

31 August 2019 (16:05 - 16:20)
Organised by:
Congress Presentation Part of: What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF Stroke Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Frank Cools

General Hospital Klina, Brasschaat (Belgium)

6 More presentations in this session

Presentation thumbnail
What have registries taught us? New insights from GARFIELD-AF
Professor A. Kakkar (London, GB)
Slides Video
Presentation thumbnail
Long-term outcomes
Professor D. Atar (Oslo, NO)
Slides Video
Presentation thumbnail
Innovations in risk assessment: an integrated risk tool for stroke, death and bleeding
Professor K. Fox (Edinburgh, GB)
Slides Video
Presentation thumbnail
Management of care in atrial fibrillation patients: impact of following guidelines for treatment of atrial fibrillation and comorbid conditions
Professor J. Camm (London, GB)
Slides Video
Presentation thumbnail
Three-way comparison of effectiveness among different classes of oral anticoagulants: GARFIELD-AF study
Professor S. Goto (Isehara, JP)
Slides Video

Access the full session

Session thumbnail
What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF

The Event

Event poster

ESC Congress 2019

31 August 2019 16:05 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources